Cruxer Insulin Vial Cooler Travel Case (Purple),Keep Medication Vial Cool — Portable Insulated Diabetic Medicine Travel Bag,TSA Approved,Small Bottle Storage Kit with Reusable Ice Brick Cooler
Organizers & Travel Kits - 产品分析报告
  • Benchmark ASIN
    B0G4DN98ZH
  • Marketplace
    US
  • Category ID
    3761461
  • Analyzed Products
  • Keyword
    home health
  • Price Range
    -
  • Minimum Net Profit Margin
    10.00%
  • MOQ
    100
  • Est. Purchasing Cost
    ¥12.80estimated
  • Data Date
    2026-07-26
  • Your Budget (for new listing) (CNY)
    ¥500,000.00
Profitability Difficulty
Unknown
Unknown - Insufficient New Releases
Newly Released Counts (All Brands)
2
New Brand (2)
Old Brand (0)
Success rate (all brands)
50.00%
New Brand (50.00%)
Old Brand (0%)
Most products net profit margin range
N/A
Listing

Report summary from Keble AI Agent: Listing

结论很明确:这个市场不适合小商家盲目进入,也不适合把它当成低门槛红海机会。 现有数据里只有 Cruxer 这一家新品牌跑出了可验证盈利,且成功依赖的是功能差异化而不是低价铺货;这说明市场不是没机会,而是只有有资源、能做产品升级的人才有机会,小品牌如果没有明显创新点,基本打不动。

Recommended Products Features Direction
B0G4DN98ZH
Why do customers choose it?
  • 紫色外观在同类医药保温包中更醒目,偏女性/个性化审美
  • 小型硬壳拉链旅行盒造型,内部为专用冰砖+双瓶位布局
  • 专为胰岛素/肽类小瓶设计的专用冰砖,强调10小时以上保冷
  • 需要随身冷藏胰岛素小瓶、短途旅行或日常外出携药的糖尿病用户
  • Sales
    Avg. price: $21.34|Latest price: $21.99|Approx. recent monthly revenue: $4,268.00 (200 pcs)|Net profit margin: 21.33%

    These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.

    New Brands
    VS
    Old Brands
    1 new brands0 old brands
    1 brands have new listings0 brands have new listings
    2 new listings0 new listings
    1 succeeded
    0 succeeded
    0 failed
    0 failed

    Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.

    New Brands

      How much did others invest?

      Collapse
    • #Budget Requirement

      Listing

      结论很明确:这个市场当前不适合入场,用户预算500,000 CNY可以覆盖单个ASIN的早期启动,但市场本身更像是“高门槛、靠差异化吃饭”的类型,不是稳妥型机会。 现有样本里只有 Cruxer 这一家新品牌出现可验证的盈利案例,而且它并不是靠低价硬拼,而是靠专用功能差异化做出来的;这说明能活下来的不是普通跟卖型产品,而是有明确创新点、且需要一定投放和产品设计能力的产品。

      Early sourcing + logistics + marketing budget (USD)
      N/A
      Explains the budget

      With all these investments, who has profitable new releases

      How many new listings are released by old brands?
      0.00%
      New listing success rate (new brands):
      50.00%
      Which new brands have these successful new listings?
      Alternatives
      1. 普通小型保温包/午餐保冷包 + 冰袋:更便宜、在超市和电商都容易买到,临时外出时也能满足短时冷藏需求。
      2. 一次性保冷凝胶冰袋 + 软质拉链收纳袋:无需专门医药配件,价格低、替换方便,适合短途通勤或临时出门。
      3. 可重复使用的医药冷藏盒/小号疫苗保温盒:通常比专用胰岛素旅行盒更通用,适合需要偶尔携带温敏药物但不想买单一场景产品的人。
      4. 带冰盒的小型便携化妆包/电子配件收纳包改造方案:通过低成本收纳包自行搭配冰袋,使用门槛低且可按需更换内部配置。
      5. 医院药房或药品配送附带的临时保冷方案:很多用户可直接利用原包装、药房保温袋或配送保温材料,几乎零额外成本。

      Alternative solutions may pose a risk to your investment in certain markets.

    • #Brands Investment Analysis

      Listing

      结论很直接:这个市场不值得进入。 目前样本里只有 2 个可判断产品,表面上看 Cruxer 这类新品牌用一个新品 B0G4DN98ZH(售价 $21.34)做到 21.33% 利润、月销 200、月收入约 $426,800,像是能赚钱;但这更像是单点成功,不是可复制的市场机会,因为可见样本太小,且一旦进入需要靠“专用功能+差异化外形”才打得动,普通跟卖空间很弱。

      Cruxer
      Least investment in new productsMost investment in new productsNew products with Highest revenue
      Cruxer Insulin Vial Cooler Travel Case (Purple),Keep Medication Vial Cool — Portable Insulated Diabetic Medicine Travel Bag,TSA Approved,Small Bottle Storage Kit with Reusable Ice Brick Cooler
      Recent Monthly Revenue (USD):$4,268.00(200pcs/month)
      B0G4DN98ZH (4.8/5 (19 Reviews))Brand is a new entry in this market
      New ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
    • #Differentiations

      Unique productsCommon products
      Cruxer Insulin Vial Cooler Travel Case (Purple),Keep Medication Vial Cool — Portable Insulated Diabetic Medicine Travel Bag,TSA Approved,Small Bottle Storage Kit with Reusable Ice Brick Cooler
      Differentiation:
      1. Product features and designs are too common without differentiation
      B0G4DN98ZH (4.8/5 (19 Reviews))Brand is a new entry in this market
      New ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
    • What net profit margin are others making?

      Collapse
    • #Net Profit Margins: All vs New

      Listing

      这个市场不值得进入。 目前只看到 2 个可判定利润样本,表面上 100% 都在盈利,但这不是健康信号,而是样本过少、市场覆盖极窄;更关键的是,已出现 Cruxer 这一新品牌把利润做出来,说明门槛不低、但还不足以证明普通新卖家能稳定复制。

      Profitability difficulty
      Unknown - Insufficient New Releases

      All products distribution on different profit levels

      All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.

      x < -10.0%
      -10.0% <= x < 0.0%
      0.0% <= x < 10.0%
      10.0% <= x < 20.0%
      20.0% <= x < 30.0%
      30.0% <= x < 40.0%
      x >= 40.0%
      other

      New products distribution on different profit levels

      This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'

      x < -10.0%
      -10.0% <= x < 0.0%
      0.0% <= x < 10.0%
      10.0% <= x < 20.0%
      20.0% <= x < 30.0%
      30.0% <= x < 40.0%
      x >= 40.0%
      other
    • #Top Products by Net Profit Margin

      Top 20 Profitable Products

      Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.

      B0G4DN98ZH
      B0G4DN98ZH
      Cruxer
      2026-01-29
      Yes
      $21.34
      200pcs
      $4268.0
      21.33%
      $910.37

      Top 20 Profitable New Products

      Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.

      B0G4DN98ZH
      B0G4DN98ZH
      Cruxer
      2026-01-29
      Yes
      $21.34
      200pcs
      $4268.0
      21.33%
      $910.37
    • Is this a good time to enter the market?

      Collapse
    • #New Product Success Rates

      Listing

      这个市场可以进入,但对新手并不友好:它不是低门槛红海,真正能赚钱的新品很少,且成功基本靠“老产品思路+功能差异化”而不是纯粹铺货。对大品牌来说,能靠资源和品牌效应切入;对小商家来说,只有少数真正做出差异化的新品才有机会,不能走低预算同质化路线。

      从数据看,市场里已出现Cruxer 这样的新品牌样本,且它的新品 B0G4DN98ZH 是明确盈利的:售价 21.34美元,月销量 200件,月收入 4268美元,毛利率 21.33%;按更高运输成本情景,利润率仍有 18.57%,但若走更贵的空运情景就会掉到 11.67%,甚至进一步压到 8.91%,说明这个品类对物流和成本极其敏感。它之所以能赢,不是靠噱头,而是靠基于旧ASIN做功能升级:紫色外观更醒目、硬壳旅行盒结构、专用冰砖、双瓶位、强调10小时保冷,目标用户非常明确——胰岛素/肽类小瓶随身冷藏需求。品牌层面,Cruxer目前可识别的盈利产品比例是 100%,新产品盈利率也是 100%,但样本只有这一个盈利新品,说明这是“单点成功”,还不能证明新品牌普遍容易成功;同时该品牌还有一个无法判断盈利的新品,意味着它并非稳态成熟玩家。市场总体的新产品盈利率显示为 50%,并不算差,但这远没达到你要求的“高风险崩盘”线;不过从现有样本看,成功几乎都集中在少数品牌和少数产品上,竞争并不是普惠型机会。

      New products success rate.

      What is the ratio of profitable products

      Profitable (Unidentifiable released date)
      Profitable (Old product)
      Profitable (New product)
      Profitable (New product on old listing)
      New products but non profitable

      Profitable new products divide by brands

      What is the ratio of different brands owning all profitable new products

      Cruxer
      No data available
    • #Success Rate by Entry Time

      Listing

      结论很明确:这个市场目前不适合进入,至少不是给大多数新品牌或小商家准备的市场。 现有数据只看到 1 个新品牌 Cruxer 的成功样本,且它的成功更像是靠“基于旧款做功能升级 + 明确差异化”换来的,不是一个已经证明对大量新手开放的市场;因此,我不会把它判断成高胜率机会。

      How many products released each year

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

      How many products released each month

      Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing

    • #Net Profit Margins by Entry Time

      Different profit ratios of products released in year

      Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.

      Time/Profit%x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other
      202200000000
      202300000000
      202400000000
      202500000000
      202600001001
      ≥ 10% Profitable
      < 10% Unprofitable
      Unidentifiable

      Different profit ratios of products released in month

      Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.

      Time/Profit%x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other
      2025/700000000
      2025/800000000
      2025/900000000
      2025/1000000000
      2025/1100000000
      2025/1200000000
      2026/100001000
      2026/200000000
      2026/300000000
      2026/400000000
      2026/500000000
      2026/600000000
      ≥ 10% Profitable
      < 10% Unprofitable
      Unidentifiable
    • What factors contribute to success or failure?

      Collapse
    • #Case Study

      Success Cases
      Cruxer Insulin Vial Cooler Travel Case (Purple),Keep Medication Vial Cool — Portable Insulated Diabetic Medicine Travel Bag,TSA Approved,Small Bottle Storage Kit with Reusable Ice Brick Cooler
      Price (USD)
      $21.34
      Released Type
      New Release (2026-01-29)
      Brand is a new entry in this market
      Size and Weight
      21.8 x 12.7 x 6.3 cm, 422.00g

      Profitable Factors

      Based on old ASINDistinct functions and features

      Design & Appearance

      紫色外观在同类医药保温包中更醒目,偏女性/个性化审美, 小型硬壳拉链旅行盒造型,内部为专用冰砖+双瓶位布局

      Key Buying Motive

      专为胰岛素/肽类小瓶设计的专用冰砖,强调10小时以上保冷

      Target Customers

      需要随身冷藏胰岛素小瓶、短途旅行或日常外出携药的糖尿病用户

      Early Investment

      Investment

      Monthly Revenue (Recent) (USD)
      $4,268.00
      200 sold in the past 30 days · as of 2026年7月

      Net Profit Margin

      Sea Freight
      18.57% / 21.33%
      Peak / Non Peak
      Rail Freight
      - / -
      Peak / Non Peak
      Air Freight
      8.91% / 11.67%
      Peak / Non Peak

      Sales & BSR Performance

    What is Keble?

    Keble is an e-commerce AI Agent that helps sellers solve daily e-commerce issues. This report is generated by Keble AI.

    Analyze Product Opportunity with Keble
    1. One report to tell you whether to enter the market or not, significantly reducing inventory risk.
    Keble AI Agent